Here are the DEF 14A proxy statements from T3 Defense Inc. (DFNS) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow DFNS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DFNS filings page.
T3 Defense Inc. asks stockholders to approve four proposals at its November 30, 2026 special meeting: a Second 2026 Equity Incentive Plan with 1,275,000 shares available if approved; board authority for one or more reverse splits at ratios from 1-for-2 to 1-for-250 within two years; an equity award agreement for CEO and director Menachem Shalom; and authority to adjourn to seek additional proxies if needed.
If approved, the plan would permit options, restricted stock, restricted stock units and stock appreciation rights. Under Shalom’s proposed award agreement, quarterly share issuances would target 8% beneficial ownership on a fully diluted basis while he remains CEO or another officer or director; if he is no longer CEO or affiliated with T3, the agreement provides for shares to bring his ownership to 15%. No shares may be issued unless stockholders approve, including approval by a majority of votes cast by stockholders other than Shalom and his affiliates.
A reverse split would require the Board to proceed and file an amendment; the Board may abandon it before it takes effect. Authorized shares would remain unchanged, leaving more common shares available for future issuance. T3 says it regained compliance with Nasdaq’s $1.00 minimum bid price requirement after its July 2026 1-for-125 reverse split.
T3 Defense Inc. is asking stockholders to vote at its virtual 2026 annual meeting on August 5, 2026. Proposals include electing four directors (CEO Menachem Shalom plus three independent directors), ratifying Somekh Chaikin (a KPMG member firm) as independent external auditor for 2026, and approving a 2026 Evergreen Equity Incentive Plan.
The equity plan would initially reserve 22,000,000 shares of common stock, with an automatic annual increase of up to 8% of the then-available pool for up to ten years, subject to board reduction. As of July 9, 2026, there were 126,311,902 common shares outstanding and 10 shares of Series B Convertible Preferred Stock (10,000 votes each), totaling 126,411,902 votes. CEO Menachem Shalom beneficially owns 14,859,080 common shares (including warrants), or 11.13% of common stock.
The proxy details 2025 director and executive compensation, including Shalom’s 2025 total compensation of $3,967,500 and a new consulting agreement effective January 1, 2026 providing a $60,000 monthly base fee, target cash bonuses, 250,000 shares per quarter (subject to plan availability and stockholder approval), potential relocation grant, and severance protections. It also describes the Star 26 acquisition structure and various related-party financings, as well as audit fees paid to GreenGrowth for 2024–2025.
T3 Defense Inc. is soliciting stockholder approval at a virtual Special Meeting on to approve four proposals: (1) authorization for issuance of Common Stock upon exercise of Warrants issued in the February 24, 2026 private placement, (2) waiver of the Preferred Exchange Cap to permit conversion of Series B Preferred Stock, (3) a Board-authorized reverse stock split within a 1-for-2 to 1-for-250 range, and (4) an adjournment authorization to solicit additional proxies.
The proxy materials state there were 60,270,525 shares of Common Stock and 200 shares of Series B Preferred Stock outstanding as of the Record Date, and that the February 2026 transaction involved 400 units for aggregate proceeds of $20,000,000. The Board unanimously recommends voting FOR all proposals.
T3 Defense Inc. is asking stockholders to approve several capital actions tied to a February 2026 $20 million private placement and its Nasdaq listing status. Investors will vote on issuing up to 14,084,506 shares of common stock upon warrant exercise and allowing conversion of Series B preferred stock above a 19.99% Nasdaq dilution cap.
The company also seeks authority for a reverse stock split at a ratio between 1‑for‑2 and 1‑for‑250 to help regain compliance with Nasdaq’s $1.00 minimum bid requirement after receiving a deficiency notice. A fourth proposal would allow adjournment of the special meeting to solicit additional votes if needed. The board unanimously recommends voting “FOR” all four proposals.